Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Lymphedema may throw off balance in breast cancer survivors

NCT ID NCT07420725

Knowledge-focused Sponsor: Kayseri City Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether breast cancer-related lymphedema (arm swelling) affects walking, balance, and fall risk. Researchers will compare 42 women with lymphedema to healthy women of similar age. They will measure gait, balance, fear of falling, and arm function using standard tests.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If this study finds clear links, it could help design fall-prevention programs for breast cancer survivors with lymphedema.
What could go wrong
This is a small observational study (42 people) that only measures differences, not treatments. Results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 42 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2026

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Female patients aged 18-65 years who presented to the Lymphedema outpatient clinic of the Physical Medicine and Rehabilitation Department at Kayseri City Hospital with upper extremity swelling following breast cancer surgery and/or radiation therapy and were diagnosed with BRCL (Group 1: LG, lymphedema group) will be included in the study. The control group (Group 2: KG) will consist of age- and gender-matched volunteer participants who presented to the Physical Medicine and Rehabilitation outpatient clinics with non-specific pain complaints and who did not have any postural, neurological, or orthopedic disorders.

Ages

18 to 65 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Women aged 18-65 with breast cancer-related ISL Stage 2-3 unilateral upper extremity breast cancer-related lymphedema * Healthy female control group matched for age and gender with the patient group aged 18-65 * Participants who agreed to participate in the study and provided written consent Exclusion Criteria: * Presence of underlying diseases that may affect extremity volume other than lymphedema * Presence of phleboedema, lipedema, cellulitis, lymphocele * Presence of acute infection * Presence of acute/chronic lung disease (history of acute pulmonary embolism, acute bronchial asthma attack, chronic interstitial lung disease) * Chronic liver failure * Renal dysfunction * Uncontrolled hypertension and diabetes mellitus * Presence of orthopedic diseases that may impede walking (joint limitation, ankylosis, amputation) * Patients who refused to participate in the study * Patients who lacked cooperation and compliance

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer lymphedema are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Breast Cancer Lymphedema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer lymphedema

Contacts and locations

Locations

  • Kayseri City Hospital

    Kayseri, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.